stockrowGlaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.
- Revenue
- +58.0%
- EPS
- +112.2%
- Free cash flow
- +411.2%
- Total debt
- −2.25%
Quarter to September 2026, against a year earlier
Follow GKOS
Alert me
Glaukos Corporation (GKOS) Free cash flow
Glaukos Corporation's free cash flow for fiscal 2025 was −$39.1M, compared with −$67.6M in fiscal 2024. Over the twelve months to 30 September 2026 it was $36.0M. Over the past ten years it has ranged from −$78.0M (fiscal 2023) to $19.8M (fiscal 2017); the current reading is higher than 36% of that period. Glaukos Corporation ranks 32nd of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$39.1M | — |
| FY2024 | −$67.6M | — |
| FY2023 | −$78.0M | — |
| FY2022 | −$63.2M | — |
| FY2021 | −$23.1M | — |
| FY2020 | −$29.9M | — |
| FY2019 | −$5.1M | — |
| FY2018 | $8.5M | (56.78%) |
| FY2017 | $19.8M | 227.97% |
| FY2016 | $6.0M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $36.5M | 201.95% |
| Jun 2026 | $12.1M | — |
| Mar 2026 | −$16.5M | — |
| Dec 2025 | $3.9M | — |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $1.1B |
| GMED Globus Medical, Inc. compare | $766.6M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| PODD Insulet Corporation compare | $260.0M |
| BRKR Bruker Corporation compare | $244.7M |
| PEN Penumbra, Inc. compare | $200.3M |
| GKOS Glaukos Corporation | $36.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on GKOS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement